Reference,Reference: DOI,Assay,Section,Pre-vaccine Infection,Vaccine,# Shots,Months,Host,Control,Control: NT50 Cmp,Control: NT50 GeoMean,Control: NT50 GSD,Variant,Variant: Pos,Variant: Mutations,# Results,Potency: NT50 Cmp,Potency: NT50 GeoMean,Potency: NT50 GSD,Fold Reduction: Cmp,Fold Reduction: Median
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,1808.0,1.0,Delta,19,T19R + T95I + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,437.0,1.0,=,4.1
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,1260.0,1.0,Delta,19,T19R + T95I + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,400.0,1.0,=,3.2
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,2651.0,1.0,Delta,19,T19R + T95I + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,873.0,1.0,=,3.0
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,3242.0,1.0,Delta,19,T19R + T95I + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,812.0,1.0,=,4.0
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,2270.0,1.0,Delta,19,T19R + T95I + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,614.0,1.0,=,3.7
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,2610.0,1.0,Delta,19,T19R + T95I + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,859.0,1.0,=,3.0
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,1215.0,1.0,Delta,19,T19R + T95I + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,529.0,1.0,=,2.3
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,1046.0,1.0,Delta,19,T19R + T95I + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,341.0,1.0,=,3.1
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,1808.0,1.0,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,1101.0,1.0,=,1.6
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,1260.0,1.0,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,717.0,1.0,=,1.8
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,2651.0,1.0,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,728.0,1.0,=,3.6
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,3242.0,1.0,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,1875.0,1.0,=,1.7
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,2270.0,1.0,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,1818.0,1.0,=,1.2
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,2610.0,1.0,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,993.0,1.0,=,2.6
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,1215.0,1.0,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,460.0,1.0,=,2.6
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,1046.0,1.0,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,406.0,1.0,=,2.6